2007
DOI: 10.1097/fjc.0b013e31813c6cc3
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of ET-1-induced Endothelial Dysfunction

Abstract: There is now increasing evidence that endothelial dysfunction is an early event in the pathophysiology of cardiovascular diseases and can be corrected with certain therapies such as angiotensin converting enzyme inhibitors angiotensin type I receptor antagonists and stains independently of blood pressure lowering effects. Restoring endothelial function appears to be a crucial target since endothelial dysfunction predicts cardiovascular events in various situations such as coronary artery disease peripheral art… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
92
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 130 publications
(94 citation statements)
references
References 102 publications
1
92
0
1
Order By: Relevance
“…In addition to its vasoconstricting properties, ET-1 has been reported to mediate vessel remodeling by interacting with growth factors and cytokines. Further actions of ET-1 are the promotion of vascular inflammation and excessive oxidative stress (32,33 ).…”
Section: Discussionmentioning
confidence: 99%
“…In addition to its vasoconstricting properties, ET-1 has been reported to mediate vessel remodeling by interacting with growth factors and cytokines. Further actions of ET-1 are the promotion of vascular inflammation and excessive oxidative stress (32,33 ).…”
Section: Discussionmentioning
confidence: 99%
“…The over-expression of endothelin-1 can inhibit the activity of endothelial NO synthase, and thereby decreasing NO level and bioavailability [23,24]. When the delicate balance between NO and ET-1 is disturbed, endothelial dysfunction may occur.…”
Section: Discussionmentioning
confidence: 99%
“…1 Endothelial dysfunction is characterized by an imbalance between endotheliumderived contracting factors, including ET-1, angiotensin II and prostaglandin endoperoxides, and endothelium-derived relaxing factors-nitric oxide, prostacyclin (PGI 2 ) and endothelium-derived hyperpolarizing factor, comprising potassium ions, epoxyeicosatrienoic acid, C-type natriuretic peptide, hydrogen peroxide (H 2 O 2 )-responsible for nitric oxide-independent VSCM hyperpolarization and vasorelaxation. [3][4][5] The presence of endothelial dysfunction was confirmed in ageing and in number of diseases, including hypertension, hypercholesterolemia, diabetes, renal failure and congestive heart failure. [3][4][5] As a potent mitogen for glomerular mesangial cells and VSMCs, ET-1 promotes cell growth, migration and proliferation.…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5] The presence of endothelial dysfunction was confirmed in ageing and in number of diseases, including hypertension, hypercholesterolemia, diabetes, renal failure and congestive heart failure. [3][4][5] As a potent mitogen for glomerular mesangial cells and VSMCs, ET-1 promotes cell growth, migration and proliferation. 1,4,6 Through the activation of mitogen-activated protein kinase, it stimulates cardiomyocyte hypertrophy.…”
Section: Introductionmentioning
confidence: 99%